Tenet Healthcare Corporation
Every calculator, already run for THC
Open the full toolkit →You have the numbers on THC. Get the argument.
A written report on which of these readings actually decide the outcome for Tenet Healthcare Corporation, what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
22 analysts covering THCAnalyst Price Target Disagreement for Tenet Healthcare Corporation
Wall Street's bull case implies +21% from the current price; the bear case implies -0%. Analysts are relatively aligned on THC's range.
Ownership & short interest
Insider Trading Activity for THC
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Tenet Healthcare Corporation
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and ne…
THC — frequently asked
Is THC a buy right now?
Wall Street's consensus rating on Tenet Healthcare Corporation is Strong Buy across 22 analysts, with a mean price target of $285.10 (+9% vs. the current $261.11). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is THC overvalued?
THC trades at 10.1x trailing earnings, against a DCF fair value of $688 per share. The current price implies -7% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is THC's next earnings date?
Tenet Healthcare Corporation is next scheduled to report earnings around Oct 27, 2026. A full THC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Tenet Healthcare Corporation?
Analysts covering Tenet Healthcare Corporation (THC) range from a bear-case target of $260.00 to a bull-case high of $315.00, with a mean consensus target of $285.10 across 21 analysts. The spread of $55.00 (21% of the current price) indicates moderate disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Tenet Healthcare Corporation against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Tenet Healthcare Corporation
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full THC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Tenet Healthcare Corporation, in minutes. 3 free reports included with every account — no credit card required.